Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INWK
5476
DELISTED
InnerWorkings, Inc.
INWK
| $116K | ﹤0.01% |
30,559
+13,195
| +76% | +$48K |
|
5477
Chemung Financial Corp
CHMG
$393M
| $115K | ﹤0.01% |
2,362
+1,164
| +97% | +$55.5K |
|
5478
Citi Trends
CTRN
$582M
| $115K | ﹤0.01% |
7,921
+3,502
| +79% | +$59.9K |
|
|
MRSN
5479
DELISTED
Mersana Therapeutics
MRSN
| $115K | ﹤0.01% |
1,132
+590
| +109% | +$69.5K |
|
5480
Rush Enterprises Class B
RUSHB
$6.1B
| $115K | ﹤0.01% |
6,941
+3,377
| +95% | +$59.7K |
|
5481
CALL
Banco Santander
SAN
$206B
| $115K | ﹤0.01% |
26,087
| – | – |
|
5482
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $115K | ﹤0.01% |
4,528
-1,600
| -26% | -$40.2K |
|
5483
Willis Lease Finance
WLFC
$1.74B
| $115K | ﹤0.01% |
5,895
+3,129
| +113% | +$52.8K |
|
|
NAGE
5484
Niagen Bioscience
NAGE
$281M
| $115K | ﹤0.01% |
24,649
+13,386
| +119% | +$57.1K |
|
5485
AstroNova
ALOT
$224M
| $114K | ﹤0.01% |
4,407
+2,771
| +169% | +$70.4K |
|
5486
Princeton Bancorp
BPRN
$289M
| $114K | ﹤0.01% |
3,790
+2,021
| +114% | +$60K |
|
|
AGNT
5487
AGNT Inc
AGNT
$674M
| $114K | ﹤0.01% |
20,562
-37,722
| -65% | -$200K |
|
5488
NI Holdings
NODK
$318M
| $114K | ﹤0.01% |
6,485
+3,511
| +118% | +$59.7K |
|
|
OPTN
5489
DELISTED
OptiNose
OPTN
| $114K | ﹤0.01% |
1,071
+683
| +176% | +$90K |
|
5490
Preformed Line Products
PLPC
$1.75B
| $113K | ﹤0.01% |
2,044
+1,106
| +118% | +$57.9K |
|
|
SUP
5491
DELISTED
Superior Industries International
SUP
| $113K | ﹤0.01% |
32,573
+14,110
| +76% | +$64.9K |
|
5492
Crawford & Co Class A
CRD.A
$552M
| $112K | ﹤0.01% |
+10,708
| New | +$97.7K |
|
5493
CALL
Open Text
OTEX
$6.34B
| $112K | ﹤0.01% |
2,700
-2,200
| -45% | -$87.6K |
|
5494
PUT
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.14B
| $112K | ﹤0.01% |
450
+380
| +543% | +$83.7K |
|
|
RLH
5495
DELISTED
Red Lions Hotel Corporation
RLH
| $112K | ﹤0.01% |
15,785
-39,840
| -72% | -$307K |
|
|
VSI
5496
DELISTED
Vitamin Shoppe Inc.
VSI
| $112K | ﹤0.01% |
28,495
-114,935
| -80% | -$594K |
|
5497
CALL
Canadian National Railway
CNI
$76.1B
| $111K | ﹤0.01% |
1,200
-7,400
| -86% | -$680K |
|
5498
Lesaka Technologies
LSAK
$401M
| $111K | ﹤0.01% |
27,737
-17,677
| -39% | -$63.4K |
|
5499
Sutro Biopharma
STRO
$416M
| $111K | ﹤0.01% |
973
+792
| +438% | +$87.3K |
|
|
PGNX
5500
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $111K | ﹤0.01% |
18,000
+7,500
| +71% | +$36.2K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.